(in the order of last name)
Dr. Eric Bouteiller – International Advisor, Honorary Chairman of RDPAC and French Trade Advisor. Formerly General Manager of Ipsen China (2001–2011) and the company’s Senior Vice President for Asia Operations (2012-2017). Formerly Chairman for Tianjin Chapter of EUCCC (2008 to 2011) and formerly Vice Chairman (2011-2015) and Chairman (2016-2017) of RDPAC. (https://www.linkedin.com/in/eric-bouteiller-43136310/)
Dr. Rob Bryant – Principal, Brychem Business Consulting; and ex-Glaxo executive
Peter Chua – President, Association of Hong Kong Healthcare Professionals; Member, the Pharmacy & Poisons Board of the Hong Kong Government; President, Huatai Pharmaceutical, Hong Kong; Director, Beijing United Pharmaceutical; Justice of Peace (HK); and former President, Hong Kong Pharmaceutical Society.
Dr. Vivian Chen – Vice President, Corporate Affairs & Market Access, Ascletis Biotech; Formerly Senior Director, Abbott China; Vice President, Corporate Affairs & Government Relations, Eli Lilly China; and Director of Healthcare Economic Policy, RDPAC.
Stanley Lau – Co-Founder, iiTalent; and formerly COO, EddingPharm; President, China Biological Products Inc.; GM - Baxter China; GM – Schering Plough China; GM Asia – Searle/Pharmacia; and GM MSD - Taiwan
Simon Luo – Director of Operations and Country Manager, IQVIA Greater China; Board Director, Chinese Hospital Association; Senior Advisor, National Institute of Hospital Administration under the Ministry of Health; Advisor, China Association of Pharmaceutical Commerce; and Advisor, China Association of Chain Drug Stores.
Robert Pollard – Formerly Managing Director Asia Pacific, P/S/L Group Market Research; and Director Synovate Healthcare China.
Dr. Xiaomei Li Reckford – Formerly Vice President, China Strategic Growth, Quintiles Transnational Corporation; and CEO, Quintiles Greater China
Dr. Yan Yan L Starkey – Head of medical affairs, Great China and India, GE Healthcare, Life Science; and formerly Director, New Product Research China Liaison at GlaxoSmithKline Consumer Healthcare.
Dr. Dong Xie – Chairman and CEO, Frontier Biotechnology Ltd.
Cheryl Q. Xu – Public Policy & GA, Biogen; and formerly Advisor on China, Pharmaceutical Research and Manufacturers of America (PhRMA)
Dr. Weiping Yang – CEO, ApolloBio; and formerly President, Nanjing Tongrentang Pharma; Chairman and CEO, Fresenius Kabi China; and Director, RDPAC